Michael Hsler - MCH Group Group Board
| MCHN Stock | CHF 3.56 0.07 2.01% |
Insider
Michael Hsler is Group Board of MCH Group AG
| Age | 51 |
| Phone | 41 58 206 20 20 |
| Web | https://www.mch-group.com |
MCH Group Management Efficiency
The company has return on total asset (ROA) of (0.0334) % which means that it has lost $0.0334 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0302) %, meaning that it generated substantial loss on money invested by shareholders. MCH Group's management efficiency ratios could be used to measure how well MCH Group manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Franziska Stein | Implenia AG | N/A | |
| Roger Albrecht | Rieter Holding AG | 41 | |
| Thomas Meier | Santhera Pharmaceuticals Holdin | 61 | |
| Valerio Signorelli | Ascom Holding AG | N/A | |
| Marc Schrader | Santhera Pharmaceuticals Holdin | N/A | |
| Dario Eklund | Santhera Pharmaceuticals Holdin | 55 | |
| Olaf Hendriks | Ascom Holding AG | N/A | |
| Pierre Blanc | Leclanche SA | 53 | |
| Dominik Maurer | Ascom Holding AG | 55 | |
| Gaby Hunziker | Ascom Holding AG | N/A | |
| Thomas Anwander | Rieter Holding AG | 63 | |
| Rico Randegger | Rieter Holding AG | 50 | |
| Paul Lawrence | Ascom Holding AG | N/A | |
| German Grniger | Implenia AG | 54 | |
| Eva Kalias | Santhera Pharmaceuticals Holdin | N/A | |
| Pasquale Foglia | Leclanche SA | N/A | |
| Oliver Strub | Santhera Pharmaceuticals Holdin | 60 | |
| Kurt Ledermann | Rieter Holding AG | 55 | |
| Silvan Merki | Implenia AG | N/A | |
| Suzanne Mhlemann | Leclanche SA | 57 | |
| Daniel Lack | Ascom Holding AG | N/A | |
Management Performance
| Return On Equity | -0.0302 | |||
| Return On Asset | -0.0334 |
MCH Group AG Leadership Team
Elected by the shareholders, the MCH Group's board of directors comprises two types of representatives: MCH Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MCH. The board's role is to monitor MCH Group's management team and ensure that shareholders' interests are well served. MCH Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MCH Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Birgit Rieder, Head Devel | ||
| Michel LorisMelikoff, Jewellery Watch | ||
| Florian Faber, Group Board | ||
| Jonas Scharf, Managing Venues | ||
| Christian Jecker, Head Sec | ||
| Michael Hsler, Group Board | ||
| Roman Imgruth, Managing Events |
MCH Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is MCH Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0302 | |||
| Return On Asset | -0.0334 | |||
| Profit Margin | (0) % | |||
| Operating Margin | (0.06) % | |||
| Current Valuation | 285.79 M | |||
| Shares Outstanding | 31.05 M | |||
| Shares Owned By Insiders | 78.41 % | |||
| Shares Owned By Institutions | 3.56 % | |||
| Price To Earning | 8.58 X | |||
| Price To Book | 4.40 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for MCH Stock Analysis
When running MCH Group's price analysis, check to measure MCH Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MCH Group is operating at the current time. Most of MCH Group's value examination focuses on studying past and present price action to predict the probability of MCH Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MCH Group's price. Additionally, you may evaluate how the addition of MCH Group to your portfolios can decrease your overall portfolio volatility.